CLINICAL TRIALS PROFILE FOR TEDUGLUTIDE RECOMBINANT
✉ Email this page to a colleague
All Clinical Trials for Teduglutide Recombinant
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00081458 ↗ | Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome | Completed | Shire | Phase 3 | 2004-05-25 | The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS). |
| NCT00172185 ↗ | Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) | Completed | Shire | Phase 3 | 2005-01-10 | The purpose of this clinical study is to evaluate the long-term safety and efficacy of daily administration of teduglutide. |
| NCT00308438 ↗ | Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 | Completed | Shire | Phase 2 | 2004-03-01 | The purpose of the study is to determine whether an investigational compound, ALX-0600, is safe and effective in treating Crohn's Disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Teduglutide Recombinant
Condition Name
Clinical Trial Locations for Teduglutide Recombinant
Trials by Country
Clinical Trial Progress for Teduglutide Recombinant
Clinical Trial Phase
Clinical Trial Sponsors for Teduglutide Recombinant
Sponsor Name
